Medical Device Decoration A Decision Framework for Regulated Manufacturers

When a medical device manufacturer calls me to ask about decorating their device, the conversation that follows is different from almost any other decoration conversation I have. In other markets — industrial parts, plastic closures, sporting goods — we open by asking how many changeovers the line runs and how many SKUs are in the portfolio. Those are still the questions that decide the labor economics in medical, too. But in medical, they aren’t the first questions. They’re the second.

The first question is regulatory: what’s the regulatory class of the part you’re decorating? Is the surface you’re putting ink on going to contact the body? Because in medical decoration, the regulatory class of the part decides which technology is allowed to be in the conversation. Once a device has FDA approval, changing the decoration system — including changing the ink — means going back through regulatory. And the ROI required to justify that path is enormous.

Most medical device manufacturers I talk to are working inside a constraint they sometimes don’t articulate to a decoration vendor: the line running today has been validated, and re-validating is the most expensive thing they can do.

Two Questions, Not One

In medical decoration, there are two diagnostic questions, asked in sequence.

The first is regulatory class. Is the part body-contact? If yes — if the surface you’re decorating sits inside the body, against the body, or in a fluid path that reaches the body — the answer is automated pad printing. Not because pad is faster, cheaper, or higher-quality than digital alternatives, but because pad inks are solvent-based and have been regulated for body-contact applications, including USP Class VI biocompatibility, for decades. Digital UV inks have not been through the same regulatory journey for body-contact applications, and they will not be through it on a normal capital-equipment cycle.

This is the structural reason EPS dominates catheter printing globally and has for decades. It is not a marketing achievement. It is a regulatory floor under pad printing that competing technologies cannot displace at the speed of equipment turnover.

The second question is the standard EPS diagnostic. If the part is not body-contact — if you’re decorating the exterior of a syringe barrel, the housing of a peripheral device, the body of a consumable that doesn’t touch the patient — the conversation reverts to the same labor-lever math we run in any other decoration market. How many changeovers? How many SKUs? What’s the throughput requirement? The technology choice depends on the same two labor levers — changeover labor and production-speed labor — that decide every other decoration market.

Body-Contact: Why Pad Dominates and Will Continue To

In medical decoration, the body-contact segment is a pad-only market. The clearest example is the catheter.

A catheter requires decoration that includes length markings, diameter indicators, brand identification, and sometimes lot codes — all printed on a long, flexible polymer tube that will be inserted into a patient’s body. The ink has to adhere reliably, survive the device’s sterilization cycle if there is one, and meet USP Class VI biocompatibility requirements. The decoration isn’t branding; it’s part of the device’s clinical performance. Length markings on a catheter are read by the clinician inserting it. Wrong markings, faded markings, or markings that fail biocompatibility testing are catastrophic in different ways.

EPS has engineered catheter decoration cells for decades. The line running today at one of our long-standing catheter customers is the same line — in concept and in substrate-ink-pretreatment system — that we engineered for them years ago. Proven, validated, reliable. The customer is not interested in changing it, and we are not interested in telling them they should.

This is the part of the medical decoration story that often gets lost in industry coverage that focuses on digital innovation: there is a substantial segment of medical decoration where the right answer is the answer that has been running for decades, and the right vendor is the one that engineered it correctly the first time and continues to support it.

Non-Body-Contact: Where Digital Plays

Once the part is not body-contact, the conversation opens. Two patterns recur.

Multi-pass digital for low-volume variable-data applications. UDI compliance is increasingly mandating variable data on medical devices — unique device identifiers, lot codes, expiration dates, sometimes serialization or anti-counterfeit marks. For lower-volume devices where variable data is the dominant decoration requirement, multi-pass digital is the right answer. It changes over in seconds (no plate change, no ink change), prints variable data at line speed, and integrates inline with inspection systems that verify every part.

Single-pass digital for higher-volume applications. Syringes are the most common example. A syringe barrel requires brand decoration, volume graduations, lot codes, and in many cases UDI marking — all at production volumes that justify single-pass throughput. Single-pass digital on the EPS XD-70 platform delivers the changeover speed of multi-pass with the throughput required for production-volume syringe lines.

Pad-and-digital combinations on the same line. For some device families, particularly syringes and externally decorated consumables, the optimal architecture is pad for the durable brand decoration plus digital for the variable-data layer. Pad lays down the brand identity and graduations that don’t change between SKUs; digital adds the lot code, UDI, or batch identifier that does. Both engineered into the same cell, both running at production speed.

Sterilization, Cleanroom, and the System Match

Medical decoration has technical considerations that don’t show up in other markets. The depth EPS engineers around them is the substantive part of “we engineer the decoration cell, not just sell you the printer.”

Sterilization compatibility. Whether the printed surface has to survive a sterilization cycle depends on the device. Single-use devices — disposable syringes, single-use diagnostics, sterile-packed consumables — don’t require sterilization-cycle survival because the part is used once and discarded. Reusable devices do, and the cycle matters: ETO, gamma, autoclave, and e-beam each create different chemical and physical stresses on a printed surface. The ink chemistry we specify for a given application is matched to the sterilization cycle the device will see, just as it is matched to the substrate, the pretreatment, and the regulatory class. There isn’t a single ink that survives every cycle; the answer is engineered to the application.

Cleanroom integration. EPS can build decoration cells for cleanroom integration when the device manufacturer requires it. Cleanroom compatibility is an engineered option, not a default — the class depends on the device’s regulatory requirements and the customer’s facility.

Substrate qualification and documented testing. Every medical decoration engagement we take begins with substrate qualification and documented adhesion testing — cross-hatch per ASTM D3359, plus the application-specific tests required for the device’s intended use. The documentation that comes out of that testing is part of what the customer takes to their internal QA and, where applicable, to regulatory submission. The system match — ink, substrate, pretreatment, cure, and where required, sterilization survival — is the engineering deliverable.

That engineering produces a measurable outcome: decoration cells that run at scrap rates well below 1%, the threshold any production medical decoration line has to maintain for both unit economics and the downstream consequence of a defective decorated part reaching the patient.

What Medical Customers Worry About

In any conversation about a medical decoration line, two concerns dominate, in this order.

Regulatory inertia. The single largest barrier in medical decoration is the cost of revalidating a system that already has FDA approval. Customers walk into the conversation knowing that any change — any change — carries a regulatory cost. The ROI required to justify that path is high, and most customers will not undertake it unless an external factor is forcing the question: a brand-program expansion, a UDI mandate, a sterilization cycle change, a customer-side specification update. Our answer to this barrier is honesty. If your current line is running and validated, we are not going to recommend you change it. The conversations where change is the right answer are conversations where a regulatory or program-side trigger has already made the question unavoidable.

ROI. Once the regulatory question is resolved — either because the part is non-body-contact and standard ROI math applies, or because a regulatory trigger has already required revalidation — the conversation reverts to the labor-lever math we run anywhere else. Changeover labor, production-speed labor, capital cost against the projected savings. The ROI Calculator on our website runs the math.

The third barrier most decoration vendors push in medical — that digital is somehow categorically the future and customers should switch before they have to — is not a barrier we push. Medical decoration is one of the few markets where the right vendor recommendation is often to stay exactly where you are.

How to Decide on Your Own Line

The diagnostic for a medical decoration decision is a two-step sequence.

First, classify the part. Body-contact, USP Class VI biocompatibility required, or any application where the decorated surface is in the fluid path or in direct patient contact — pad is the answer, period. Either keep the pad line you have or engineer a new pad cell if you don’t have one. EPS engineers both.

Second, if the part is non-body-contact, run the standard labor-lever diagnostic. Count your changeovers per week and the operator labor those changeovers consume. Estimate your production-speed gap to the available digital alternative. Identify whether variable data — UDI, lot codes, serialization — is now a requirement on the line. If changeover labor or variable-data capability is the dominant cost or constraint, digital is the answer; if not, pad continues to be.

The Decoration Optimizer on our website walks through both steps. The ROI Calculator runs the second-step math with your inputs. Both return automated pad as the recommendation when pad is the right answer — which in medical decoration is more often than the marketing of other decoration vendors would suggest.

If you want to talk through a specific situation — regulatory class, current line, sterilization requirements, validation status, where digital might or might not fit — the contact form is on every page, or drop a note directly. The engineer who reads it will be the one who’d actually engineer your cell.

About the author — Jakob Izzo is a Territory manager at Engineered Printing Solutions, where he leads both the Northeast and West territories. He has spent 15 years working with medical device manufacturers and contract decorators to engineer the substrate-ink-pretreatment systems that meet USP Class VI biocompatibility, sterilization, and validation requirements for body-contact and non-body-contact medical decoration. He can be reached at jizzo@epsvt.com.